ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,600Medicare Part D Prescriptions Filled, Including Refills

Rank: 236 out of 1942

$368K Total Retail Price of All Prescriptions

Rank: 290 out of 1942

433 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 433 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 433 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,739 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 379 342 1 1
LEVOTHYROXINE SODIUM 334 311 2 3
OMEPRAZOLE 329 279 3 4
POTASSIUM CHLORIDE 268 251 4 17
FUROSEMIDE 253 238 5 5
ATENOLOL 235 227 6 7
LISINOPRIL 199 184 7 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 175 159 8 22
HYDROCHLOROTHIAZIDE 170 165 9 8
METOPROLOL TARTRATE 159 148 10 9
PRAVASTATIN SODIUM 158 153 11 23
AMLODIPINE BESYLATE 157 150 12 6
CITALOPRAM HBR 156 126 13 15
WARFARIN SODIUM 148 131 14 11
HYDROCODONE-ACETAMINOPHEN 145 113 S3 15 12
METOPROLOL SUCCINATE 130 125 16 13
ZOLPIDEM TARTRATE 119 93 17 25
METFORMIN HCL ER 118 102 18 46
ATORVASTATIN CALCIUM 95 89 19 14
ALLOPURINOL 85 85 20 26
PROAIR HFA 82 64 21 41
POLYETHYLENE GLYCOL 3350 81 69 22 28
DIGOXIN 75 72 23 40
TAMSULOSIN HCL 75 65 23 29
VENLAFAXINE HCL ER 70 51 25 70
SERTRALINE HCL 68 64 26 20
VERAPAMIL ER 68 68 26 122
PREDNISONE 68 60 26 27
METHYLPREDNISOLONE 66 58 29 191
ALENDRONATE SODIUM 62 62 30 21
ADVAIR DISKUS 61 35 31 35
LANTUS SOLOSTAR 58 44 32 54
FLUTICASONE PROPIONATE 56 34 33 37
GEMFIBROZIL 53 42 34 60
LEVOFLOXACIN 53 43 34 157
NAMENDA 52 52 36 51
DIOVAN HCT 50 43 37 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.